Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-446,852
Closed -$202K 5065
2025
Q2
$202K Sell
446,852
-357,623
-44% -$156K ﹤0.01% 3975
2025
Q1
$327K Buy
804,475
+287,677
+56% +$185K ﹤0.01% 3675
2024
Q4
$342K Buy
516,798
+251,789
+95% +$175K ﹤0.01% 4060
2024
Q3
$225K Buy
+265,009
New +$203K ﹤0.01% 3621
2024
Q2
Sell
-189,160
Closed -$246K 4706
2024
Q1
$246K Buy
189,160
+165,235
+691% +$173K ﹤0.01% 3512
2023
Q4
$13.7K Buy
23,925
+4,500
+23% +$3.11K ﹤0.01% 3924
2023
Q3
$14.6K Buy
+19,425
New +$14.8K ﹤0.01% 3712
2023
Q1
Sell
-742,446
Closed -$713K 3870
2022
Q4
$713K Buy
742,446
+715,167
+2,622% +$1.01M ﹤0.01% 2062
2022
Q3
$59K Buy
+27,279
New +$94.1K ﹤0.01% 2851
2022
Q2
Sell
-37,905
Closed -$191K 3426
2022
Q1
$191K Sell
37,905
-24,181
-39% -$122K ﹤0.01% 2491
2021
Q4
$389K Sell
62,086
-108,346
-64% -$740K ﹤0.01% 2312
2021
Q3
$1.35M Sell
170,432
-91,701
-35% -$755K ﹤0.01% 1391
2021
Q2
$1.96M Buy
262,133
+35,477
+16% +$248K 0.01% 1195
2021
Q1
$1.37M Buy
226,656
+110,625
+95% +$851K 0.01% 1289
2020
Q4
$663K Buy
+116,031
New +$738K ﹤0.01% 1598

Other funds holding VXRT

Squarepoint's VXRT Position: Q3 2025 in Review

Squarepoint sold out of Vaxart (VXRT) in Q3 2025, closing a stake of 446,852 shares — an estimated $202K sold.

Squarepoint first reported a position in VXRT in Q4 2020 and held it in 15 quarters. The position peaked at $1.96M in Q2 2021. 17 funds tracked by Wall St. Rank hold VXRT as of Q3 2025.

  • Squarepoint reported no remaining Vaxart position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 446,852 Vaxart shares in Q3 2025, an estimated $202K.
  • Squarepoint first reported a position in Vaxart in Q4 2020 and held it in 15 quarters.
  • Squarepoint's Vaxart position peaked at $1.96M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Vaxart as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.